Literature DB >> 2766456

Expression of mammalian O6-alkylguanine-DNA alkyltransferase in a cell line sensitive to alkylating agents.

M E Dolan1, L Norbeck, C Clyde, N K Hora, L C Erickson, A E Pegg.   

Abstract

Chinese hamster ovary cells (CHO) were co-transfected with pSV2neo and sheared DNA from either a human cell line (HT29) expressing high levels of O6-alkylguanine-DNA alkyltransferase (AGT) or from a cell line (BE) deficient in this activity. Cells expressing the selectable marker were obtained by exposure to G418 and colonies resistant to alkylation damage isolated by growth in the presence of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU). The number of colonies of cells expressing AGT activity arising after transfection with DNA from BE cells was similar to the number arising from cells exposed to HT29 DNA. Although the amount of AGT repair protein expressed in the transfectant colonies from this experiment was relatively low, these results indicate that repair of alkylation damage can be restored in AGT-deficient cells by transfection of human DNA from both repair-deficient and proficient cells. A separate transfection of CHOMG cells [a mutant of CHO cells resistant to the drug, methylglyoxal bis(guanylhydrazone) (MGBG)] with HT29 DNA and pSV2neo followed by selection of G418 and 1,3-bis-(2-chloroethyl)-1-nitrosourea (BCNU) resulted in three colonies with high AGT levels. These transfectants had different growth rates and expressed levels of the AGT protein between 230 and 300 fmol/mg protein. The transfectants were as resistant to the cytotoxic effects of BCNU, Clomesone, methylnitrosourea (MNU) and 1-methyl-3-nitro-1-nitrosoguanidine (MNNG) as HT29 cells which were much more resistant than the parental CHOMG cells. Pretreatment of transfectant cells with 0.4 mM O6-methylguanine for 24 h reduced AGT activity to 14% basal levels, which upon removal of the base increased to approximately 74% basal level within 8 h. The sensitivity to the cytotoxic effects of both the chloroethylating and methylating agents was enhanced by treatment with O6-methylguanine. In the same manner, the number of BCNU-induced DNA interstrand cross-links increased in transfectant cells pretreated with O6-methylguanine. These results provide further evidence that the formation of methyl or chloroethyl adducts at the O6-position contribute significantly to cell lethality.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2766456     DOI: 10.1093/carcin/10.9.1613

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  11 in total

Review 1.  Resistance to cytostatic drugs at the cellular level.

Authors:  C P Vendrik; J J Bergers; W H De Jong; P A Steerenberg
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

Review 2.  Context Matters: Contribution of Specific DNA Adducts to the Genotoxic Properties of the Tobacco-Specific Nitrosamine NNK.

Authors:  Lisa A Peterson
Journal:  Chem Res Toxicol       Date:  2016-12-08       Impact factor: 3.739

Review 3.  Identification of human genes involved in repair and tolerance of DNA damage.

Authors:  B Kaina; G Fritz; T Coquerelle
Journal:  Radiat Environ Biophys       Date:  1991       Impact factor: 1.925

4.  Depletion of mammalian O6-alkylguanine-DNA alkyltransferase activity by O6-benzylguanine provides a means to evaluate the role of this protein in protection against carcinogenic and therapeutic alkylating agents.

Authors:  M E Dolan; R C Moschel; A E Pegg
Journal:  Proc Natl Acad Sci U S A       Date:  1990-07       Impact factor: 11.205

5.  Genotoxic and cytotoxic effects of 4-aroyl-1-nitrosohydrazine-carboxamides on O6-alkylguanine-DNA alkyltransferase-positive and -negative human cell lines.

Authors:  C Schell; O Lantermann; W Popp; C Vahrenholz; J Thomale; R Gugova; E Golovinsky; K Norpoth
Journal:  J Cancer Res Clin Oncol       Date:  1994       Impact factor: 4.553

6.  The influence of repair pathways on the cytotoxicity and mutagenicity induced by the pyridyloxobutylation pathway of tobacco-specific nitrosamines.

Authors:  Li Li; Joana Perdigao; Anthony E Pegg; Yanbin Lao; Stephen S Hecht; Bruce R Lindgren; Joyce T Reardon; Aziz Sancar; Elizabeth V Wattenberg; Lisa A Peterson
Journal:  Chem Res Toxicol       Date:  2009-08       Impact factor: 3.739

7.  Treatment of subcutaneous and intracranial brain tumor xenografts with O6-benzylguanine and 1,3-bis(2-chloroethyl)-1-nitrosourea.

Authors:  G M Felker; H S Friedman; M E Dolan; R C Moschel; C Schold
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

8.  In vivo depletion of O6-alkylguanine-DNA-alkyltransferase in lymphocytes and melanoma of patients treated with CB 10-277, a new DTIC analogue.

Authors:  S M Lee; N Thatcher; D Crowther; G P Margison
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

9.  Role of aldehydes in the toxic and mutagenic effects of nitrosamines.

Authors:  Lisa A Peterson; Anna M Urban; Choua C Vu; Meredith E Cummings; Lee C Brown; Janel K Warmka; Li Li; Elizabeth V Wattenberg; Yesha Patel; Daniel O Stram; Anthony E Pegg
Journal:  Chem Res Toxicol       Date:  2013-09-25       Impact factor: 3.739

10.  O6-methylguanine induces altered proteins at the level of transcription in human cells.

Authors:  John A Burns; Kristian Dreij; Laura Cartularo; David A Scicchitano
Journal:  Nucleic Acids Res       Date:  2010-08-11       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.